MELD score, child-pugh score, and decreased albumin as risk factors for gastric variceal bleeding

Hepato-Gastroenterology

Volumn 56, Issue 94-95, 2009, Pages 1552-1556

  Soga, Koichi ^a   Tomikashi, Koichi ^b   Miyawaki, Ki Ichirou ^a   Fukumoto, Kohei ^a   Wakabayashi, Naoki ^a   Konishi, Hideyuki ^a   Mitsufuji, Shoji ^a   Yoshida, Norimasa ^a   Kokura, Satoshi ^a   Naito, Yuji ^a   Kataoka, Keisho ^a   Yoshikawa, Toshikazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Kohoku General Hospital   (Japan)

Author keywords

Child Pugh score; Gastric variceal bleeding; MELD score; Portal hypertension; Serum albumin

Indexed keywords

SERUM ALBUMIN;

ARTICLE; CHILD PUGH SCORE; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGUS VARICES BLEEDING; FEMALE; GASTRIC VARICEAL BLEEDING; HUMAN; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MULTIVARIATE ANALYSIS; PORTAL HYPERTENSION; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; STOMACH HEMORRHAGE;

ESOPHAGEAL AND GASTRIC VARICES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEPATIC VEINS; HUMANS; MALE; RISK FACTORS; SERUM ALBUMIN; SEVERITY OF ILLNESS INDEX; VENOUS PRESSURE;

EID: 71949117539     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. de Franchis R, Primignani M: Natural history of portal hypertension in patients with cirrhosis. Clin Liver Dis 2001; 5: 645-663.
2. Sharara AI, Rockey DC: Gastroesophageal variceal hemorrhage. N Engl J Med 2001; 345: 669-681.
3. Burroughs AK, McCormick PA: Natural history and prognosis of variceal bleeding. Baillieres Clin Gastroenterol 1992; 6: 437-450.
4. Zaman A, Hapke R, Flora K, Rosen H, Benner K: Prevalence of upper and lower gastrointestinal tract findings in liver transplant candidates undergoing screening endoscopic evaluation. Am J Gastroenterol 1999; 94: 895-899. (Pubitemid 29173598)
5. Trudeau W, Prindiville T: Endoscopic injection sclerosis in bleeding gastric varices. Gastrointest Endosc 1986; 32: 264-268. (Pubitemid 16044277)
6. Sarin SK, Lahoti D, Saxena SP, Murthy NS, Makwana UK: Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patiente. Hepatology 1992; 16: 1343-1349.
7. Kim T, Shijo H, Kokawa H, Tokumitsu H, Kubara K, Ota K, Akiyoshi N, Iida T, Yokoyama M, Okumura M: Risk factors for hemorrhage from gastric fundal varices. Hepatology 1997; 25: 307-312. (Pubitemid 27069047)
8. Paquet KJ, Oberhammer E: Sclerotherapy of bleeding oesophageal varices by means of endoscopy. Endoscopy 1978; 10: 7-12. (Pubitemid 8280466)
9. Calès P, Zabotto B, Meskens C, Caucanas JP, Vinel JP, Desmorat H, Fermanian J, Pascal JP: Gastroesophageal endoscopic features in cirrhosis. Observer variability, interassociations, and relationship to hepatic dysfunction. Gastroenterology 1990; 98: 156-162.
10. Witzel L, Wolbergs E, Merki H: Prophylactic endoscopic sclerotherapy of oesophageal varices. A prospective controlled study. Lancet 1985; 1: 773-775.
11. del Olmo JA, Pena A, Serra MA, Wassel AH, Benages A, Rodrigo JM: Predictors of morbidity and mortality after the first episode of upper gastrointestinal bleeding in liver cirrhosis. J Hepatol 2000; 32: 19-24. (Pubitemid 30039442)
12. Kokawa H, Shijo H, Kubara K, Nakaoka K, Toriya H, Shirai Z, Okazaki M: Long-term risk factors for bleeding after first course of endoscopic injection sclerotherapy: a univariate and multivariate analysis. Am J Gastroenterol 1993; 88: 1206-1211. (Pubitemid 23219713)
13. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D'Amico G, Dickson ER, Kim WR: A model to predict survival in patients with end stage liver disease. Hepatology 2001; 33: 464-470. (Pubitemid 32119037)
14. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, Kremers W, Lake J, Howard T, Merion RM, Wolfe RA, Krom R: United Network for Organ Sharing Liver Disease Severity Score Committee: The model for end stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 91-96.
15. Chalasani N, Kahi C, Francois F, Pinto A, Marathe A, Bini EJ, Pandya P, Sitaraman S, Shen J: Model for end stage liver disease (MELD) for predicting mortality in patients with acute variceal bleeding. Hepatology 2002; 35: 1282-1284. (Pubitemid 34454029)
16. van Ijperen M, Bambha KM, Malinchoc M, Kremers WK, Kim WR, Wiesner RH, Kamath PS: Model for end stage liver disease (MELD) predicts survival in patients with variceal bleeding. J Hepatol 2003; 38 (Suppl 2): 73.
17. Hashizume M, Kitano S, Yamaga H, Koyanagi N, Sugimachi K: Endoscopic classification of gastric varices. Gastrointest Endosc 1990; 36: 276-280.
18. The Japan Society for Portal Hypertension: The general rules for study of portal hypertension. 2nd ed. Tokyo: Kanehara Co., 2004: 37-50.
19. de Franchis R, Pascal J, Ancona E, Burroughs AK, Henderson M, Fleig W, Groszmann R, Bosch J, Sauerbruch T, Soederlund C, Lebrec D, Soerensen TIA, Pagliaro L: Definitions, methodology and therapeutic strategies in portal hypertension. A consensus development workshop. Baveno, Lake Maggiore, Italy, April 5-6, 1990. J Hepatol 1992; 15: 256-261.
20. Amitrano L, Guardascione MA, Bennato R, Manguso F, Balzano A: MELD score and hepatocellular carcinoma identify patients at different risk of short-term mortality among cirrhotics bleeding from esophageal varices. J Hepatol 2005; 42: 820-825. (Pubitemid 40693198)
21. Kameda N, Higuchi K, Shiba M, Kadouchi K, Machida H, Okazaki H, Tanigawa T, Watanabe T, Tominaga K, Fujiwara Y, Nakamura K, Arakawa T: Management of gastric fundal varices without gastro-renal shunt in 15 patients. World J Gastroenterol 2008; 14: 448-453.
22. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC: A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864-871. (Pubitemid 30169932)
23. Tan PC, Hou MC, Lin HC, Liu TT, Lee FY, Chang FY, Lee SD: A randomized trial of endoscopic treatment of acute gastric variceal hemorrhage: N-butyl-2-cyanoacrylate injection versus band ligation. Hepatology 2006; 43: 690-697.
24. Watanabe K, Kimura K, Matsutani S, Ohto M, Okuda K: Portal hemodynamics in patients with gastric varices. A study in 230 patients with esophageal and/or gastric varices using portal vein catheterization. Gastroenterology 1988; 95: 434-440. (Pubitemid 18183770)
25. Arakawa M, Masuzaki T, Okuda K: Pathomorphology of esophageal and gastric varices. Semin Liver Dis 2002; 22: 73-82.
26. Garcia-Tsao G, Groszmann RJ, Fisher RL, Conn HO, Atterbury CE, Glickman M: Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology 1985; 5: 419-424. (Pubitemid 15065948)
27. Viallet A, Marleau D, Huet M, Martin F, Farley A, Villeneuve JP, Lavoie P: Hemodynamic evaluation of patients with intrahepatic portal hypertension. Relationship between bleeding varices and the portohepatic gradient. Gastroenterology 1975; 69: 1297-1300.
28. de Franchis R: Updating consensus in portal hypertension. Report of the Baveno III consensus workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000; 33: 846-852.
29. Casado M, Bosch J, Garcia-Pagan JC, Bru C, Bañares R, Bandi JC, Escorsell A, Rodríguez-Láiz JM, Gilabert R, Feu F, Schorlemer C, Echenagusia A, Rodés J: Clinical events following transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings. Gastroenterology 1998; 114: 1296-1303. (Pubitemid 28243916)
30. Groszmann RJ, Bosch J, Grace ND, Conn HO, Garcia-Tsao G, Navasa M, Alberts J, Rodes J, Fischer R, Bermann M, Rofe S, Patrick M, Lerner E: Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology 1990; 99: 1401-1407.
31. Pagliaro L: MELD: the end of Child-Pugh classification? J Hepatol 2002; 36: 141-142.
32. Said A, Williams J, Holden J, Remington P, Gangnon R, Musat A, Lucey MR: Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 2004; 40: 897-903.
33. Brinch K, Moller S, Bendtsen F, Becker U, Henriksen JH: Plasma volume expansion by albumin in cirrhosis. Relation to blood volume distribution, arterial compliance and severity of disease. J Hepatol 2003; 39: 24-31. (Pubitemid 36724104)
34. Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R, Escorsell A, Garcia-Pagan JC, Makuch R, Patch D, Matloff DS, Bosch J: Portal Hypertension Collaborative Group: Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology 2007; 133: 481-488.
35. Goodfriend TL, Elliott ME, Catt KJ: Angiotensin receptors and their antagonists. N Engl J Med 1996; 334: 1649-1654.
36. Laragh JH, Angers M, Kelly WG, Lieberman S: Hypotensive agents and pressor substances: the effect of epinephrine, norepinephrine, angiotensin II, and others on the secretory rate of aldosterone in man. JAMA 1960; 174: 234-240.
37. Pinzani M, Failli P, Ruocco C, Casini A, Milani S, Baldi E, Giotti A, Gentilini P: Fat-storing cells as liver specific pericytes. Spatial dynamics of agonist stimulated intracellular calcium transients. J Clin Invest 1992; 90: 642-646.
38. Garcia-Tsao G: Portal hypertension. Curr Opin Gastroenterol 1997; 13: 263-270.
39. Rockey D: The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin, and nitric oxide. Hepatology 1997; 25: 2-5.
40. Vandekerckhoffe A, Keppens S, De Wulf H: The angiotensin II receptor of rabbit hver: characterization in isolated hepatocytes and effect of GTP. J Endocrinol 1989; 123: 131-136. (Pubitemid 19254942)
41. Schneider AW, Kalk JF, Klein CP: Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis. Hepatology 1999; 29: 334-339. (Pubitemid 29088434)